01 3Cipher Pharmaceuticals Inc.
02 3GlaxoSmithKline Inc.
03 2Valeant Canada LP
01 32098108
02 12211389
03 12351463
04 12455633
05 12647123
06 12782779
01 3ACYCLOVIR
02 3Acyclovir
03 2Acyclovir | Hydrocortisone
01 2Cream
02 3TABLET
03 3Tablet
01 32012-01-29
02 12016-02-02
03 12019-11-12
04 12022-07-23
05 12027-03-23
06 12030-12-09
Patent Expiration Date : 2019-11-12
Date Granted : 2009-10-13
Brand Name : XERESE
Patent Number : 2351463
Filing Date : 1999-11-12
Strength per Unit : 5% / 1%
Dosage Form : Cream
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2019-11-12
Date Granted : 2009-10-13
Patent Expiration Date : 2016-02-02
Date Granted : 2007-11-20
Brand Name : XERESE
Patent Number : 2211389
Filing Date : 1996-02-02
Strength per Unit : 5% / 1%
Dosage Form : Cream
Human Or VET : Human
Route of Administration : Topical
Patent Expiration Date : 2016-02-02
Date Granted : 2007-11-20
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Brand Name : ZOVIRAX
Patent Number : 2098108
Filing Date : 1992-01-29
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Brand Name : ZOVIRAX
Patent Number : 2098108
Filing Date : 1992-01-29
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Brand Name : ZOVIRAX
Patent Number : 2098108
Filing Date : 1992-01-29
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-01-29
Date Granted : 2001-07-03
Patent Expiration Date : 2022-07-23
Date Granted : 2012-05-01
Brand Name : SITAVIG
Patent Number : 2455633
Filing Date : 2002-07-23
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : BUCCAL
Patent Expiration Date : 2022-07-23
Date Granted : 2012-05-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-03-23
Date Granted : 2013-08-06
Brand Name : SITAVIG
Patent Number : 2647123
Filing Date : 2007-03-23
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : BUCCAL
Patent Expiration Date : 2027-03-23
Date Granted : 2013-08-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-09
Date Granted : 2015-07-14
Brand Name : SITAVIG
Patent Number : 2782779
Filing Date : 2010-12-09
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : BUCCAL
Patent Expiration Date : 2030-12-09
Date Granted : 2015-07-14
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
